Panacea Biotec joins hands with US-based Refana to develop COVID-19 vaccine

By: |
Published: June 10, 2020 12:35 PM

The company in partnership with Refana aims to manufacture over 500 million doses of COVID-19 candidate vaccine, with over 40 million doses expected to be available for delivery early next year, he added.

Both Panacea and Refana will undertake sales and distribution of the vaccine in their respective territories, it added.

Panacea Biotec on Wednesday said it is setting up a joint venture firm in Ireland with US-based Refana Inc to develop a vaccine for COVID-19. The company is advancing its response to address the unprecedented challenges of COVID-19 by collaborating with Refana Inc to make a vaccine widely accessible around the world in an equitable manner through a joint venture company to be based in Ireland, Panacea Biotec said in a regulatory filing.
The collaboration aims to bring to patients a whole inactivated virus-based vaccine for COVID-19, it added.

As per the partnership, Panacea Biotec will be responsible for product development and commercial manufacturing, while the JV entity undertaking clinical development and regulatory submissions across the world.  Both Panacea and Refana will undertake sales and distribution of the vaccine in their respective territories, it added.

“The world needs a vaccine that is safe, effective, and scalable in a Current Good Manufacturing Practice (cGMP) compliant manufacturing facility that has sizeable capacity and capability to cater to global demand,” Panacea Biotec Managing Director Rajesh Jain said.

The company in partnership with Refana aims to manufacture over 500 million doses of COVID-19 candidate vaccine, with over 40 million doses expected to be available for delivery early next year, he added. Whole inactivated viral vaccines have a higher probability of being safe and efficacious, given their long history and better understanding of their mechanism of action, which has been elucidated over many decades, Jain said.

Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.

Next Stories
1Pakistan Foreign Minister Mehmood Qureshi tests positive for COVID-19
2Covid-19: Women with history of pregnancy not eligible to donate plasma in Delhi, doctors tell why
3Covaxin Covid-19 vaccine: ICMR aims for August 15 launch, health experts say “unrealistic deadline”